GigCapital3 Competitors

GigCapital3 (NYSE:GIK) and Ajax I (NYSE:AJAX) are both small-cap financial services companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.

Profitability

This table compares GigCapital3 and Ajax I's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares GigCapital3 and Ajax I's revenue, earnings per share and valuation.

Analyst Ratings

This is a summary of current ratings and target prices for GigCapital3 and Ajax I, as reported by MarketBeat.

GigCapital3 currently has a consensus price target of $15.3333, indicating a potential upside of 69.80%. Given GigCapital3's higher probable upside, research analysts plainly believe GigCapital3 is more favorable than Ajax I.

Summary

GigCapital3 beats Ajax I on 2 of the 2 factors compared between the two stocks.

Ajax I (NYSE:AJAX) and GigCapital3 (NYSE:GIK) are both small-cap unclassified companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Valuation and Earnings

This table compares Ajax I and GigCapital3's top-line revenue, earnings per share (EPS) and valuation.

Profitability

This table compares Ajax I and GigCapital3's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Ajax I and GigCapital3, as reported by MarketBeat.

GigCapital3 has a consensus target price of $15.3333, suggesting a potential upside of 69.80%. Given GigCapital3's higher possible upside, analysts clearly believe GigCapital3 is more favorable than Ajax I.

Summary

GigCapital3 beats Ajax I on 2 of the 2 factors compared between the two stocks.

GigCapital3 (NYSE:GIK) and Pontem (NYSE:PNTM) are both small-cap financial services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, dividends, risk and institutional ownership.

Profitability

This table compares GigCapital3 and Pontem's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares GigCapital3 and Pontem's top-line revenue, earnings per share and valuation.

Analyst Recommendations

This is a summary of current ratings for GigCapital3 and Pontem, as reported by MarketBeat.com.

GigCapital3 presently has a consensus target price of $15.3333, suggesting a potential upside of 69.80%. Given GigCapital3's higher probable upside, equities research analysts clearly believe GigCapital3 is more favorable than Pontem.

Summary

GigCapital3 beats Pontem on 2 of the 2 factors compared between the two stocks.

Bridgetown (NASDAQ:BTWN) and GigCapital3 (NYSE:GIK) are both small-cap unclassified companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Bridgetown and GigCapital3, as provided by MarketBeat.com.

GigCapital3 has a consensus price target of $15.3333, suggesting a potential upside of 69.80%. Given GigCapital3's higher probable upside, analysts plainly believe GigCapital3 is more favorable than Bridgetown.

Earnings and Valuation

This table compares Bridgetown and GigCapital3's gross revenue, earnings per share and valuation.

Profitability

This table compares Bridgetown and GigCapital3's net margins, return on equity and return on assets.

Summary

GigCapital3 beats Bridgetown on 2 of the 2 factors compared between the two stocks.

CM Life Sciences (NASDAQ:CMLF) and GigCapital3 (NYSE:GIK) are both small-cap financial services companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations and dividends.

Valuation and Earnings

This table compares CM Life Sciences and GigCapital3's revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for CM Life Sciences and GigCapital3, as reported by MarketBeat.

GigCapital3 has a consensus target price of $15.3333, suggesting a potential upside of 69.80%. Given GigCapital3's higher probable upside, analysts plainly believe GigCapital3 is more favorable than CM Life Sciences.

Profitability

This table compares CM Life Sciences and GigCapital3's net margins, return on equity and return on assets.

Summary

GigCapital3 beats CM Life Sciences on 2 of the 2 factors compared between the two stocks.

GigCapital3 (NYSE:GIK) and Bluescape Opportunities Acquisition (NYSE:BOAC) are both small-cap financial services companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

Profitability

This table compares GigCapital3 and Bluescape Opportunities Acquisition's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares GigCapital3 and Bluescape Opportunities Acquisition's top-line revenue, earnings per share (EPS) and valuation.

Analyst Recommendations

This is a summary of current ratings and recommmendations for GigCapital3 and Bluescape Opportunities Acquisition, as reported by MarketBeat.

GigCapital3 currently has a consensus price target of $15.3333, suggesting a potential upside of 69.80%. Given GigCapital3's higher possible upside, research analysts clearly believe GigCapital3 is more favorable than Bluescape Opportunities Acquisition.

Summary

GigCapital3 beats Bluescape Opportunities Acquisition on 2 of the 2 factors compared between the two stocks.